INS and early-onset autosomal dominant Alzheimer disease: Aging is one of the main risk factors for the development of T2DM, and age-related modifications in central insulin action, including changes in the insulin concentration itself or its intracellular signaling pathways seem to be pronounced in neurodegenerative diseases such as Alzheimer’s disease (AD) [14].